<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>ROBINUL- glycopyrrolateÂ tabletÂ </strong><br><strong>ROBINUL FORTE- glycopyrrolateÂ tabletÂ </strong><br>Shionogi Inc.<br></p></div>
<h1>Robinul and Robinul Forte</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-1"></a><p></p>
<h1></h1>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-2"></a><p></p>
<h1>
<span class="Bold">D</span><span class="Bold">ESCRIPTION</span>
</h1>
<p class="First">Robinul<span class="Sup">Â®</span> and Robinul<span class="Sup">Â®</span> Forte tablets contain the synthetic anticholinergic, glycopyrrolate. Glycopyrrolate is a quaternary ammonium compound with the following chemical name: 3-[(cyclopentylhydroxyphenylacetyl)oxy]-1, 1-dimethylpyrrolidinium bromide.</p>
<p><span class="Bold">Robinul </span>tablets are scored, compressed white tablets engraved HPC 200. Each tablet contains:</p>
<p>Glycopyrrolate, USP ............................................................................................................ 1 mg</p>
<p><span class="Bold">Robinul Forte </span>tablets are scored, compressed white tablets engraved HORIZON 205. Each tabletÂ contains:</p>
<p>Glycopyrrolate, USP.............................................................................................................. 2 mg</p>
<p><span class="Bold">Inactive Ingredients: </span>Dibasic Calcium Phosphate, Lactose, Magnesium Stearate, Povidone, Sodium Starch Glycolate</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-3"></a><p></p>
<h1><span class="Bold">ACTIONS</span></h1>
<p class="First">Glycopyrrolate, like other anticholinergic (antimuscarinic) agents, inhibits the action of acetylcholineÂ on structures innervated by postganglionic cholinergic nerves and on smooth musclesÂ that respond to acetylcholine but lack cholinergic innervation. These peripheral cholinergic receptorsÂ are present in the autonomic effector cells of smooth muscle, cardiac muscle, the sino-atrialÂ node, the atrioventricular node, exocrine glands, and, to a limited degree, in the autonomic ganglia.Â Thus, it diminishes the volume and free acidity of gastric secretions and controls excessiveÂ pharyngeal, tracheal, and bronchial secretions.</p>
<p>Glycopyrrolate antagonizes muscarinic symptoms (e.g., bronchorrhea, <span class="product-label-link" type="condition" conceptid="256717" conceptname="Bronchospasm">bronchospasm</span>, <span class="product-label-link" type="condition" conceptid="4169095" conceptname="Bradycardia">bradycardia</span>,Â and <span class="product-label-link" type="condition" conceptid="4010029" conceptname="Increased intestinal motility">intestinal hypermotility</span>) induced by cholinergic drugs such as the anticholinesterases.</p>
<p>The highly polar quaternary ammonium group of glycopyrrolate limits its passage across lipidÂ membranes, such as the blood-brain barrier, in contrast to atropine sulfate and scopolamineÂ hydrobromide, which are non-polar tertiary amines which penetrate lipid barriers easily.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-4"></a><p></p>
<h1><span class="Bold">INDICATIONS</span></h1>
<p class="First">For use as adjunctive therapy in the treatment of <span class="product-label-link" type="condition" conceptid="4027663" conceptname="Peptic ulcer">peptic ulcer</span>.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-5"></a><p></p>
<h1><span class="Bold">CONTRAINDICATIONS</span></h1>
<p class="First"><span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">Glaucoma</span>; <span class="product-label-link" type="condition" conceptid="194406" conceptname="Urinary tract obstruction">obstructive uropathy</span> (for example, <span class="product-label-link" type="condition" conceptid="433813" conceptname="Bladder neck obstruction">bladder neck obstruction</span> due to <span class="product-label-link" type="condition" conceptid="198803" conceptname="Benign prostatic hyperplasia">prostatic hypertrophy</span>);Â obstructive disease of the gastrointestinal tract (as in achalasia, pyloroduodenal stenosis, etc.); <span class="product-label-link" type="condition" conceptid="192357" conceptname="Paralytic ileus">paralytic ileus</span>; intestinal atony of the elderly or debilitated patient; unstable cardiovascular status in acute <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">hemorrhage</span>; severe <span class="product-label-link" type="condition" conceptid="81893" conceptname="Ulcerative colitis">ulcerative colitis</span>; toxic <span class="product-label-link" type="condition" conceptid="198465" conceptname="Megacolon, not Hirschsprung's">megacolon</span> complicating <span class="product-label-link" type="condition" conceptid="81893" conceptname="Ulcerative colitis">ulcerative colitis</span>; <span class="product-label-link" type="condition" conceptid="76685" conceptname="Myasthenia gravis">myasthenia gravis</span>. Robinul (glycopyrrolate) tablets are contraindicated in those patients with a <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to glycopyrrolate.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="section-6"></a><p></p>
<h1><span class="Bold">WARNINGS</span></h1>
<p class="First">In the presence of a high environmental temperature, <span class="product-label-link" type="condition" conceptid="437744" conceptname="Heat exhaustion">heat prostration</span> (<span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span> and <span class="product-label-link" type="condition" conceptid="4181404" conceptname="Heat stroke">heat stroke</span> dueÂ to decreased <span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">sweating</span>) can occur with use of Robinul.</p>
<p><span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">Diarrhea</span> may be an early symptom of incomplete <span class="product-label-link" type="condition" conceptid="193518" conceptname="Intestinal obstruction">intestinal obstruction</span>, especially in patientsÂ with ileostomy or colostomy. In this instance treatment with this drug would be inappropriate andÂ possibly harmful.</p>
<p>Robinul (glycopyrrolate) may produce <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span> or <span class="product-label-link" type="condition" conceptid="4079185" conceptname="Hazy vision">blurred vision</span>. In this event, the patientÂ should be warned not to engage in activities requiring mental alertness such as operating a motor vehicle or other machinery, or performing hazardous work while taking this drug.</p>
<p>Theoretically, with overdosage, a curare-like action may occur, i.e., neuro-muscular blockade leading to <span class="product-label-link" type="condition" conceptid="79908" conceptname="Muscle weakness">muscular weakness</span> and possible <span class="product-label-link" type="condition" conceptid="440377" conceptname="Paralysis">paralysis</span>.</p>
<div class="Section" data-sectionCode="42228-7">
<a name="section-6.1"></a><p></p>
<h2><span class="Bold">Pregnancy</span></h2>
<p class="First">The safety of this drug during pregnancy has not been established. The use of any drug duringÂ pregnancy requires that the potential benefits of the drug be weighed against possible hazardsÂ to mother and child. Reproduction studies in rats revealed no teratogenic effects from glycopyrrolate;Â however, the potent anticholinergic action of this agent resulted in diminished rates ofÂ conception and of survival at weaning, in a dose-related manner. Other studies in dogs suggestÂ that this may be due to diminished seminal secretion which is evident at high doses of glycopyrrolate.Â Information on possible adverse effects in the pregnant female is limited to uncontrolledÂ data derived from marketing experience. Such experience has revealed no reports of teratogenicÂ or other fetus-damaging potential. No controlled studies to establish the safety of the drug in pregnancy have been performed.</p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="section-6.2"></a><p></p>
<h2><span class="Bold">Nursing Mothers</span></h2>
<p class="First">It is not known whether this drug is excreted in human milk. As a general rule, nursing should not be undertaken while a patient is on a drug since many drugs are excreted in human milk.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="section-6.3"></a><p></p>
<h2><span class="Bold">Pediatric Use</span></h2>
<p class="First">Since there is no adequate experience in pediatric patients who have received this drug, safetyÂ and efficacy in pediatric patients have not been established.</p>
</div>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-7"></a><p></p>
<h1><span class="Bold">PRECAUTIONS</span></h1>
<p class="First">Use Robinul with caution in the elderly and in all patients with:</p>
<ul class="Disc">
<li><span class="product-label-link" type="condition" conceptid="4080146" conceptname="Autonomic neuropathy">Autonomic neuropathy</span>.<br>
</li>
<li>Hepatic or <span class="product-label-link" type="condition" conceptid="198124" conceptname="Kidney disease">renal disease</span>.<br>
</li>
<li>Ulcerative colitisâ€“large doses may suppress intestinal motility to the point of producing a paralyticÂ <span class="product-label-link" type="condition" conceptid="193518" conceptname="Intestinal obstruction">ileus</span> and for this reason may precipitate or aggravate â€œtoxic <span class="product-label-link" type="condition" conceptid="198465" conceptname="Megacolon, not Hirschsprung's">megacolon</span>,â€? a serious complication of the      disease.<br>
</li>
<li><span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">Hyperthyroidism</span>, coronary heart disease, <span class="product-label-link" type="condition" conceptid="319835" conceptname="Congestive heart failure">congestive heart failure</span>, cardiac <span class="product-label-link" type="condition" conceptid="315643" conceptname="Tachyarrhythmia">tachyarrhythmias</span>,Â <span class="product-label-link" type="condition" conceptid="315643" conceptname="Tachyarrhythmia">tachycardia</span>, <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span> and <span class="product-label-link" type="condition" conceptid="198803" conceptname="Benign prostatic hyperplasia">prostatic hypertrophy</span>.<br>
</li>
<li><span class="product-label-link" type="condition" conceptid="4224004" conceptname="Hiatal hernia">Hiatal hernia</span> associated with <span class="product-label-link" type="condition" conceptid="30437" conceptname="Gastro-esophageal reflux disease with esophagitis">reflux esophagitis</span>, since anticholinergic drugs may aggravate thisÂ condition.</li>
</ul>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-8"></a><p></p>
<h1><span class="Bold">ADVERSE REACTIONS</span></h1>
<p class="First">Anticholinergics produce certain effects, most of which are extensions of their fundamental pharmacologicalÂ actions. Adverse reactions to anticholinergics in general may include <span class="product-label-link" type="condition" conceptid="4226991" conceptname="Aptyalism">xerostomia</span>;Â decreased <span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">sweating</span>; <span class="product-label-link" type="condition" conceptid="201688" conceptname="Delay when starting to pass urine">urinary hesitancy</span> and retention; <span class="product-label-link" type="condition" conceptid="4079185" conceptname="Hazy vision">blurred vision</span>; <span class="product-label-link" type="condition" conceptid="315643" conceptname="Tachyarrhythmia">tachycardia</span>; <span class="product-label-link" type="condition" conceptid="315078" conceptname="Palpitations">palpitations</span>;Â dilatation of the pupil; <span class="product-label-link" type="condition" conceptid="375263" conceptname="Cycloplegia">cycloplegia</span>; increased ocular <span class="product-label-link" type="condition" conceptid="4200706" conceptname="Tension">tension</span>; <span class="product-label-link" type="condition" conceptid="4289517" conceptname="Loss of taste">loss of taste</span>; <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headaches</span>; <span class="product-label-link" type="condition" conceptid="436817" conceptname="Feeling nervous">nervousness</span>;Â <span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">mental confusion</span>; <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>; <span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">weakness</span>; <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>; <span class="product-label-link" type="condition" conceptid="436962" conceptname="Insomnia">insomnia</span>; <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>; <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>; <span class="product-label-link" type="condition" conceptid="75860" conceptname="Constipation">constipation</span>; <span class="product-label-link" type="condition" conceptid="4218984" conceptname="Abdominal distension">bloated feeling</span>; <span class="product-label-link" type="condition" conceptid="4216771" conceptname="Impotence">impotence</span>; suppression of lactation; severe <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergic reaction</span> or drug idiosyncrasies including <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylaxis</span>, <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span> and other dermal manifestations.</p>
<p>Robinul (glycopyrrolate) is chemically a quaternary ammonium compound; hence, its passageÂ across lipid membranes, such as the blood-brain barrier, is limited in contrast to atropine sulfateÂ and scopolamine hydrobromide. For this reason the occurrence of CNS related side effects isÂ lower, in comparison to their incidence following administration of anticholinergics which areÂ chemically tertiary amines that can cross this barrier readily.</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="section-9"></a><p></p>
<h1>
<span class="Bold">O</span><span class="Bold">VERDOSAGE</span>
</h1>
<p class="First">The symptoms of overdosage of glycopyrrolate are peripheral in nature rather than central.</p>
<ol class="Arabic">
<li>To guard against further absorption of the drugâ€“use gastric lavage, cathartics and/or enemas.<br>
</li>
<li>To combat peripheral anticholinergic effects (residual <span class="product-label-link" type="condition" conceptid="4290615" conceptname="Dilated pupil">mydriasis</span>, <span class="product-label-link" type="condition" conceptid="4226991" conceptname="Aptyalism">dry mouth</span>, etc.)â€“utilize a quaternary      ammonium anticholinesterase, such as neostigmine methylsulfate.<br>
</li>
<li>To combat hypotensionâ€“use pressor amines (norepinephrine, metaraminol) i.v.; and supportive care.<br>
</li>
<li>To combat respiratory depressionâ€“administer oxygen; utilize a respiratory stimulant such as Dopram<span class="Sup">Â®</span>Â i.v.; artificial respiration.</li>
</ol>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-10"></a><p></p>
<h1><span class="Bold">DOSAGE AND ADMINISTRATION</span></h1>
<p class="First">The dosage of Robinul<span class="Sup">Â®</span>Â or Robinul<span class="Sup">Â®</span> Forte should be adjusted to the needs of the individual patientÂ to assure symptomatic control with a minimum of adverse reactions. The presently recommended maximum daily dosage of glycopyrrolate is 8 mg.</p>
<p><span class="Bold">Robinul </span>(glycopyrrolate, 1 mg) tablets. The recommended initial dosage of Robinul for adults isÂ one tablet three times daily (in the morning, early afternoon, and at bedtime). Some patients mayÂ require two tablets at bedtime to assure overnight control of symptoms. For maintenance, aÂ dosage of one tablet twice a day is frequently adequate.</p>
<p><span class="Bold">Robinul Forte </span>(glycopyrrolate, 2 mg) tablets. The recommended dosage of Robinul Forte forÂ adults is one tablet two or three times daily at equally spaced intervals.</p>
<p>Robinul tablets are not recommended for use in pediatric patients under the age of 12 years.</p>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="section-11"></a><p></p>
<h1><span class="Bold">DRUG INTERACTIONS</span></h1>
<p class="First">There are no known drug interactions.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-12"></a><p></p>
<h1><span class="Bold">HOW SUPPLIED</span></h1>
<p class="First">Robinul<span class="Sup">Â®</span> (glycopyrrolate, 1 mg) tablets in bottles of 100 (NDC 59630-200-10).</p>
<p>Robinul<span class="Sup">Â®</span> Forte (glycopyrrolate, 2 mg) tablets in bottles of 100 (NDC 59630-205-10).</p>
<p><span class="Bold">Store at controlled room temperature, 20Â°C to 25Â°C (68Â°F to 77Â°F); excursions permitted to</span><span class="Bold">Â </span><span class="Bold">15Â°-30Â°C (59Â°-86Â°F)[see USP Controlled Room Temperature]. Keep out of reach of children.</span></p>
<p><span class="Bold">Dispense in tight container</span></p>
<p><span class="Bold">Rx only</span></p>
<p>Manufactured by:<br><span class="Bold">MIKART, INC.</span><br>Atlanta, GA 30318</p>
<p>Manufactured for:<br><span class="Bold">Shionogi Inc.</span><br>Florham Park, NJ 07932</p>
<p>ROB-PI-3</p>
<p>Rev. 12/11</p>
<p>Printed in USA</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-13"></a><p></p>
<h1><span class="Bold"><br>PRINCIPAL DISPLAY PANEL</span></h1>
<p class="First"><span class="Bold">NDC 59630-200-10   </span><span class="Bold">100 Tablets</span></p>
<p><span class="Bold">ROBINUL</span><span class="Bold"><span class="Sup">Â®</span></span><span class="Bold"><br>(glycopyrrolate tablets, USP)</span><span class="Bold"><br>1 mg</span></p>
<p><img alt="PRINCIPAL DISPLAY PANEL
NDC 59630-200-10   100 Tablets
ROBINULÂ®
(glycopyrrolate tablets, USP)
1 mg
" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=bd65ee5e-2000-423c-b0a6-72eb213455c4&amp;name=robinul-01.jpg"></p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-14"></a><p></p>
<h1><span class="Bold">PRINCIPAL DISPLAY PANEL</span></h1>
<p class="First"><span class="Bold">NDC 59630-205-10   </span><span class="Bold">100 Tablets</span></p>
<p><span class="Bold">ROBINUL</span><span class="Bold"><span class="Sup">Â®</span></span><span class="Bold"><span class="Sup">Â </span></span><span class="Bold">FORTE</span><span class="Bold"><br>(glycopyrrolate tablets, USP)</span><span class="Bold"><br>2 mg</span></p>
<p><img alt="PRINCIPAL DISPLAY PANEL
NDC 59630-205-10   100 Tablets
ROBINULÂ® FORTE
(glycopyrrolate tablets, USP)
2 mg
" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=bd65ee5e-2000-423c-b0a6-72eb213455c4&amp;name=robinul-02.jpg"></p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>ROBINULÂ 		
					</strong><br><span class="contentTableReg">glycopyrrolate tablet</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:59630-200</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>GLYCOPYRROLATE</strong> (GLYCOPYRRONIUM) </td>
<td class="formItem">GLYCOPYRROLATE</td>
<td class="formItem">1Â mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>LACTOSE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>MAGNESIUM STEARATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>POVIDONES</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">WHITE (white) </td>
<td class="formLabel">Score</td>
<td class="formItem">2 pieces</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">ROUND (ROUND) </td>
<td class="formLabel">Size</td>
<td class="formItem">8mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">HPC;200</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">Â Â Â Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:59630-200-10</td>
<td class="formItem">100  in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA012827</td>
<td class="formItem">03/28/1961</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>ROBINUL FORTEÂ 		
					</strong><br><span class="contentTableReg">glycopyrrolate tablet</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:59630-205</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>GLYCOPYRROLATE</strong> (GLYCOPYRRONIUM) </td>
<td class="formItem">GLYCOPYRROLATE</td>
<td class="formItem">2Â mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>LACTOSE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>MAGNESIUM STEARATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>POVIDONES</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">WHITE (white) </td>
<td class="formLabel">Score</td>
<td class="formItem">2 pieces</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">ROUND (ROUND) </td>
<td class="formLabel">Size</td>
<td class="formItem">10mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">HORIZON;205</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">Â Â Â Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:59630-205-10</td>
<td class="formItem">100  in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA012827</td>
<td class="formItem">03/28/1961</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler -Â </span>Shionogi Inc.
							(949127786)
						</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 12/2011<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>81777c49-9cf0-4835-b791-1b7776d70af9</div>
<div>Set id: bd65ee5e-2000-423c-b0a6-72eb213455c4</div>
<div>Version: 7</div>
<div>Effective Time: 20111201</div>
</div>
</div>Â <div class="DistributorName">Shionogi Inc.</div></p>
</body></html>
